Periodic Reporting for period 1 - proCOLON (First-in-class beta-catenin inhibitor as treatment for colorectal cancer)

With more than 1.9 million new cases and 935,000 related deaths in 2020, colorectal cancer (CRC) is the third most common cancer in men and the second in women. While surgery is the main treatment option for lower grade CRC, patients with unresectable lesions are treated with...